MeSH tree: C06.405.205.731.249
For patients with ulcerative colitis, upadacitinib is associated with improved disease-specific outcomes at 12 months compared with tofacitinib, according to a study published in the December issue of the American Journal ...
Dec 23, 2024
0
18
A simple, non-invasive treatment focused on the ears could one day provide relief for people with ulcerative colitis, a UM research study has found.
Dec 16, 2024
0
33
Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis, are marked by cycles of immune activation and inflammation that significantly impact patients' lives.
Dec 12, 2024
0
24
When you hear the words mucus and snot, you might think of colds, snails or drooling babies. But the runny, sometimes sticky substance often plays a vital role in our lives, and mucus also has the potential to be a medicine.
Dec 4, 2024
0
28
Inflammatory bowel disease (IBD) is a chronic inflammation of the digestive tract. It includes conditions such as ulcerative colitis and Crohn's disease. People with IBD may experience persistent symptoms like frequent diarrhea, ...
Dec 4, 2024
1
32
Inflammatory bowel disease (IBD) affects an estimated 1.6 million Americans. In fact, there are more than 70,000 new cases of IBD in the United States each year, according to the Crohn's & Colitis Foundation.
Dec 2, 2024
0
27
Scientists at Örebro University have identified specific protein patterns in blood tests that can predict inflammatory bowel disease (IBD) up to 16 years before diagnosis. In particular, Crohn's disease can be detected with ...
Nov 26, 2024
0
44
Researchers at Germans Trias i Pujol Research Institute (IGTP) and Institut d'Investigació Sanitària Pere Virgili (IISPV) have conducted a review on the therapeutic potential of extracellular vesicles in inflammatory bowel ...
Nov 20, 2024
0
18
A study published today in Gastroenterology provides the most comprehensive assessment to date of pediatric inflammatory bowel disease (IBD) prevalence in the United States.
Nov 20, 2024
0
16
The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of moderate-to-severe ulcerative colitis, published in Gastroenterology.
Nov 19, 2024
0
32
